Global Vaccines Market Analysis, Trends and Opportunities 2026
Summary -
A new market
study, titled “Global Vaccines s Market
Analysis, Trends and Opportunities 2026” has been featured on WiseGuyReports.
Vaccines
are biological products, acquired immunity to a particular disease or these
products protect people from severe and dreadful diseases. Unlike most other
medicines to treat or cure disease, vaccines prevent them by developing
immunity. Most of the vaccines are administered through injection
(intravenous), a few are given orally and nasal route. The emerging infectious
diseases include Middle East respiratory syndrome coronavirus (MERS-CoV),
meningococcal disease, Ebola, avian flu, swine flu and most recently zika
virus.
Market
Drivers:
Increase in
emerging infectious diseases prevalence globally, and cost-effective
immunizations are showing a significant impact on global Vaccines market and
are also expected to remain high over the forecast period.
According
to WHO in 2017, the annual epidemics in seasonal influenza globally estimated
that 3-5 million cases of severe illness and about 290,000-600,000 respiratory
deaths are observed.
According
to Centre Of Disease Control And Prevention in 2016, there were about 360 total
cases of meningococcal disease reported and most among the children below one
year old followed by adults.
Market
Segmentation
By Vaccines
Type
The global
vaccines market is segmented on vaccines type which includes influenza,
measles, smallpox, yellow fever, hepatitis A, polio, shingles, and others. The
other emerging diseases include ebola, avian flu, and most recently zika virus.
Measles
dominated the vaccines type segment for global vaccines market and expected to
remain dominant during the forecast period due to its global prevalence.
According
to WHO in 2017, more than 6.7 million people affected with measles mostly
children, and 110,000 died from the virus.
According
to Centre Of Disease Control and Prevention and control, between 2017 and
January 2018, 14,372 cases have been registered under European Surveillance
System.
By
geography
North
America dominates the global vaccines market in 2018, due to the increase in
seasonal influenza viruses around the year in the U.S and government funding
for research on effective vaccines.
According
to Centers Of Disease Control and Prevention during 2017-18 flu season, it was
estimated 80,000 Americans died due to seasonal flu, highest in last 40 years.
In 2018,
omnibus bill a single document accepted in a single vote by legislature
included $100 million monetary funds to National Institute Of Health (NIH) for
the advanced development of universal influenza vaccine.
By age
group
The global
vaccines market is segmented on age group which includes pediatrics, adults,
and geriatrics. Pediatrics dominates the global vaccines market due to its
increase in need of polio vaccines and first stage of vaccines and government
regulations.
Infants are
sensitive towards vaccine-preventable diseases because of the early immune
system development, therefore less able to fight against infection. The series
of vaccinations include Hepatitis B, polio, DTaP and DTP vaccine, rotavirus.
These provide best and safest protection against deadly diseases.
Competitive
Landscape
New vaccine
launch, joint ventures between major companies and FDA approvals on new
vaccines are driving the global vaccines market.
In December
2018, Merck & company got FDA approval for a six disease combination
vaccine vaxelis, for use in children up to the age of five years old.
In October
2018, FDA approved HPV vaccine which prevents cervical cancer, and other
malignancies are extended for use in men and women aged between 27-45 years.
In April
2018, Emergent Biosolutionss acquired specialty vaccines company PaxVax.
In October
2017, FDA approved new shingles vaccine called Shingrix, used to treat
blistering disease for the adult aged 50 and above.
In December
2016, international vaccine institutes invested $34million in Pennsylvania
biotech inovio to expand its development into MERS-CoV vaccine.
Target
Audience
• Raw
Material Suppliers/ Buyers
• Product
Suppliers/ Buyers
• Industry
Investors/Investment Bankers
• Education
& Research Institutes
• Research
Professionals
• Emerging
Companies
•
Manufacturer
FOR MORE DETAILS: https://www.wiseguyreports.com/reports/3792098-global-vaccines-market-2019-2026
About Us:
Wise Guy Reports is part of the Wise Guy Research Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe.
Contact Us:
NORAH
TRENT
Ph: +162-825-80070 (US)
Ph: +44 2035002763
(UK)
Comments
Post a Comment